4th edition new draft.pub - The University of Manchester
4th edition new draft.pub - The University of Manchester
4th edition new draft.pub - The University of Manchester
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
10<br />
Commercial study accrual update 2010-2011<br />
Study ID Acronym Study Title Active Status Recruiting sites<br />
An open-label study assessing the addition <strong>of</strong><br />
subcutaneous golimumab (GLM) to<br />
conventional disease-modifying antirheumatic<br />
drug (DMARD) therapy in biologic-naïve<br />
subjects with rheumatoid arthritis (Part 1)<br />
followed by a randomised study assessing the<br />
value <strong>of</strong> combined intravenous and<br />
subcutaneous GLM administration aimed at<br />
inducing and maintaining remission (Part 2)<br />
6678<br />
CCRN 065<br />
(RA)<br />
Closed - in<br />
follow-up<br />
<strong>Manchester</strong> Royal<br />
Infirmary/<br />
Wrightington<br />
Hospital<br />
6681<br />
CCRN 067<br />
(RA)<br />
A 3-phase study to evaluate sustained<br />
remission and productivity outcomes in<br />
subjects with early rheumatoid arthritis initiated<br />
on treatment with etanercept plus<br />
Closed - in<br />
methotrexate<br />
follow-up<br />
<strong>Manchester</strong> Royal<br />
Infirmary/<br />
Wrightington<br />
Hospital<br />
6887<br />
CCRN 078<br />
(Tendon<br />
repair)<br />
A randomised, double blind clinical<br />
investigation to evaluate the safety, tolerability,<br />
and preliminary performance <strong>of</strong> Adaprev in<br />
Improving recovery <strong>of</strong> tendon function in<br />
subjects undergoing surgical repair <strong>of</strong> flexor<br />
tendons in Zone II <strong>of</strong> the hand<br />
Closed - in<br />
follow-up<br />
Wythenshawe<br />
Hospital<br />
6989<br />
CCRN 097 (RA<br />
- TNF)<br />
A global multi-centre observational study in<br />
rheumatoid arthritis (RA) patients who are<br />
non-responders or intolerant to a single tumor<br />
necrosis factor (TNF)-inhibitor<br />
Closed - in<br />
follow-up<br />
<strong>Manchester</strong> Royal<br />
Infirmary/ Salford<br />
Royal Hospital/<br />
Stepping Hill<br />
Hospital/<br />
Wrightington<br />
Hospital<br />
6969<br />
Efficacy and safety <strong>of</strong> eslicarbazepine acetate<br />
as therapy in patients with fibromyalgia: A<br />
CCRN 098 double-blind, randomised, placebo-controlled,<br />
(Fibromyalgia) parallel-group, multicentre clinical trial<br />
Closed - in<br />
follow-up<br />
<strong>Manchester</strong> Royal<br />
Infirmary<br />
7768 MCRN067<br />
A randomized, double-blind, placebo controlled,<br />
withdrawal study <strong>of</strong> flare prevention <strong>of</strong><br />
canakinumab (ACZ885) in patients with<br />
Systemic Juvenile Idiopathic Arthritis (SJIA) and Closed - in<br />
active systemic manifestations<br />
follow-up<br />
Royal <strong>Manchester</strong><br />
Children's Hospital
Change language